Contracts › 75A50122C00072
75A50122C00072: Enalare Therapeutics: an Agnostic Respiratory Stimulant for Use As a Medical Countermeasure to Treat Respiratory Depression
Awarded to Enalare Therapeutics Inc by Office of Assistant Secretary for Preparedness and Response.
$12.2Mobligated
$56.6Mpotential value
31 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50122C00072 |
|---|---|
| Awardee | Enalare Therapeutics Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | NJ |
| Offers received | 1 |
| Period of performance | 22 September 2022 to 31 December 2026 |
| Potential end | 30 September 2028 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record